Fixed income market: the week ahead

Bonds
Althea Spinozzi

Fixed Income Strategist

Summary:  European sovereigns will rise as the ECB adds stimulus to the economy. However, the EU Summit starting on the same day as the ECB's meeting might hinder the market rally if an agreement over the Covid-19 recovery fund is not reached. The US yield curve will resume steepening amid talks of a stimulus package, and 10-year yields will test the 1% pivotal level. In the UK, Gilts will continue to rally as Brexit uncertainty weighs more on the economy than the rollout of a Covid-19 vaccine.


Prepare yourself for an exciting week where the European Central Bank meeting, Brexit and talks surrounding the fiscal stimulus package in the US will be dictating bond sentiment.

In Europe, the bond market is anxious to hear on Thursday how the ECB is planning to expand stimulus. For weeks central bankers have set high expectations for a new stimulus with Lagarde herself saying that she's willing to do whatever it takes to support the European economy. The ECB may be looking to expand the Pandemic Emergency Purchase Programme (PEPP) and to extend it until the end of 2021. If that were the case, it would undoubtedly give a boost to sovereigns in the periphery. If the ECB doesn't disappoint, we expect Portuguese 10-year yields to consolidate below 0%. Italian BTPs will offer the most significant upside as we will most likely see the spread between 10-year BTPs and the Bund falling below 100bps. It represents a tightening of approximately 17bps which will translate in a move up of roughly 2 points in BTPs' nominal prices. Italy is planning to sell up to 5.75bn of 4-year zero-coupon bonds and 7-year bonds on the same day as the central bank meeting. These auctions will be crucial to understand investors sentiment and trust towards the ECB.

The ECB meeting will not be the only noteworthy event in the European space this week. On Thursday and Friday, EU leaders will meet in Brussels to discuss the approval of the €1.8tn recovery fund. The market is currently underestimating the risk that the EU is running with Poland and Hungary exercising a veto on the Covid-19 recovering fund. On one side, there is the risk that money will not be delivered to the European economy in time. On the other, we have the frightening scenario that will see European countries dividing and potentially inducing the EU to break down. Hence while we can expect upside for European sovereigns due to the ECB meeting, a reversal is possible if an agreement is not reached this week at the EU Summit.

Talks to approve the fiscal stimulus package in the US will dictate sentiment in Treasuries this week. Treasury 10-year yields rose 6 bps and closed at 97 bps on Friday. This week, we expect them to test the 1% pivotal level. The headlines talk about a stimulus bill of $900bn in order to face front to a spike of coronavirus cases. A successful stimulus package will increase inflation expectations; hence a US yield curve steepener is expected. Longer-dated yields will rise faster lead by the 30-year. As mentioned in an earlier analysis, the key levels to watch out for are 1.50% in 10-year yields and 1.9% in 30-year yields. Critical is the testing of the 1.5% level in 10 year-yields as it will break the resistance line of Treasury yields' historical descending trending line since the mid-'80s. Hence, if yields rise above 1.5%, we will see volatility leaking to other asset classes.

In the UK, news surrounding Brexit and the rolling out of the BioNTech / Pfizer vaccine will take a central stage. The FTSE 100 has opened flat this morning while Gilts are considerably higher pointing to the fact that the market is more concerned about a hard Brexit rather than being optimistic about vaccine news. Gilts are likely to enjoy safe-haven status and rise throughout 2021 until the economy in the UK has not stabilized amid Brexit and the Covid-19 pandemic.

Monday the 7th of December

  • Japan: Outright Bond Purchases 1-3 Years and 25 Years
  • Australia: ANZ Job Advertisements, Foreign Reserves
  • South Africa: Gross and Net Reserves
  • China: Trade Balance, Foreign Reserves
  • Germany: Industrial Production
  • Eurozone: Bloomberg December Eurozone Economic Survey, Sentix Investor Confidence
  • Russia: Official Reserve Assets
  • Italy: Bank of Italy Report on Balance Sheet Aggregates
  • United States: Consumer Credit

Tuesday the 8th of December

  • Japan: Trade Balance, GDP numbers
  • France: Payrolls numbers, Trade Balance
  • Eurozone: Employment numbers, ZEW Survey Expectations, GDP numbers
  • Switzerland: Unemployment Rate
  • United States: Nonfarm Productivity, Unit Labour Costs, NFIB Small Business Optimism

Wednesday the 9th of December

  • China: Consumer Price Index
  • Germany: Trade Balance
  • United Kingdom: to sell £2.5bn bonds with 2035 maturity
  • United States: MBA Mortgage Applications, JOLTS Job Openings, US to sell 10-Year Notes reopening
  • Canada: BoC Rate Decision
  • Russia: CPI numbers

Thursday the 10th of December

  • Japan: PPI numbers
  • United Kingdom: GDP numbers, Industrial Production, Manufacturing Production, Index od Services, Trade Balance
  • Eurozone: ECB Main Refinancing Rate, ECB President Christine Lagarde Holds Press Conference, European Council meeting starts
  • Italy: selling 2.75bn Euros of 0 coupon 2024 bonds and up to 3bn Euros of 2027 Bonds
  • United States: Initial Jobless Claims, CPI Index, Bloomberg Consumer Comfort, Monthly Budget Statement, Selling 30-Year Bonds Reopening

Friday the 11th of December

  • Eurozone: European Council meeting continues
  •  Japan: BOJ Outright bond purchases across various maturities ranging from 1 to 10 years
  • Germany: Consumer Price Index
  • China: Foreign Direct Investment
  • Italy: Industrial Production, Unemployment Rate
  • United Kingdom: BoE/TNS Inflation Next 12 Months, BOE Publishes Financial Stability Report
  • Russia Trade Balance, GDP numbers
  • United States: PPI numbers, University of Michigan Sentiment and Inflation forecasts (1-, 5-, and 10-years), Fed's Quarles Discusses Bank Supervision
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.